Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Incyte Aktie: Biotech-Performer mit Vollgas


Während viele Biotech-Titel noch mit schwachem Marktumfeld kämpfen, liefert Incyte einen beeindruckenden Gegenbeweis. Das…

Der Beitrag Incyte Aktie: Biotech-Performer mit Vollgas erschien zuerst auf kapitalmarktexperten.de.


Quelle kapitalmarktexperten.de

Incyte Corp. Stock

€81.32
-1.780%
A loss of -1.780% shows a downward development for Incyte Corp..
We see a rather positive sentiment for Incyte Corp. with 16 Buy predictions and 1 Sell predictions.
With a target price of 92 € there is a slightly positive potential of 13.13% for Incyte Corp. compared to the current price of 81.32 €.

Comments